Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.42 |
| ▸ | MAOA | P21397 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 3/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | PPARA | Q07869 | 1/20 | 0.38 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.35 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.35 |
| ▸ | CES2 | O00748 | 1/20 | 0.35 |
| ▸ | CES1 | P23141 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15181513 | 0.93 | MAOA (0.52) | LMNAMAOAMAOBHPGDMEN1 | |
| SCHEMBL15850877 | 0.93 | CYP1A2 (0.42) | LMNACYP2A6MAOAMAOBHPGD | |
| SCHEMBL14477632 | 0.86 | MEN1 (0.33) | MEN1KMT2ACA1CA2CA9 | |
| SCHEMBL98774 | 0.78 | LMNA (0.47) | LMNACYP2A6MAOAMAOBHPGD | |
| SCHEMBL79980 | 0.76 | ESR2 (0.52) | LMNAHPGDMEN1KMT2ACA1 | |
| SCHEMBL2602434 | 0.74 | ACHE (0.48) | LMNAMEN1KMT2ACA1CA2 | |
| SCHEMBL819491 | 0.74 | CYP2A6 (0.42) | LMNACYP2A6MAOAMAOBMEN1 | |
| SCHEMBL819814 | 0.74 | CA1 (0.58) | CA1CA2CA9MAPTCYP3A4 | |
| SCHEMBL5148477 | 0.74 | ALDH1A1 (0.50) | MAOAMAOBHPGDMEN1KMT2A | |
| SCHEMBL121643 | 0.74 | NFE2L2 (0.37) | LMNAMAOAMAOBCA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 121 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101333226-A | Chiral dual ring [4.4.0] diborate and method for preparing same | UNIV WUHAN (CN) | 2008-12-31 | — | — | CN | claimed |
| US-20240228470-A1 | Organic Compound And Organic Light Emitting Device Including Same | P&H TECH CO., LTD (KR) | 2024-07-11 | — | — | US | disclosed |
| US-12029112-B2 | Composition for optoelectronic device and organic optoelectronic device and display device | SAMSUNG SDI CO., LTD. (KR) | 2024-07-02 | — | — | US | disclosed |
| US-20240023432-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, MANUFACTURING METHOD THEREFOR, AND COMPOSITION FOR ORGANIC LAYER | LT MATERIALS CO., LTD. (KR) | 2024-01-18 | — | — | US | disclosed |
| US-20240018103-A1 | 3-HYDROXYOXINDOLE DERIVATIVES AS CRHR2 ANTAGONIST | RAQUALIA PHARMA INC. (JP) | 2024-01-18 | — | — | US | disclosed |
| US-11840513-B2 | Substituted nicotinimide inhibitors of BTK for treating cancer | Guangzhou Innocare Pharma Tech Co., Ltd (CN) | 2023-12-12 | — | — | US | disclosed |
| US-20230389347-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-11-30 | — | — | US | disclosed |
| US-11832512-B2 | Organic electroluminescence device and monoamine compound for organic electroluminescence device | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-11-28 | — | — | US | disclosed |
| US-20230371368-A1 | LIGHT EMITTING ELEMENT AND AMINE COMPOUND FOR THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-11-16 | — | — | US | disclosed |
| US-11805697-B2 | Organic electroluminescence device and monoamine compound for organic electroluminescence device | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-10-31 | — | — | US | disclosed |
| US-20120112174-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME AND DISPLAY DEVICE INCLUDING THE ORGANIC LIGHT EMITTING DIODE | CHEIL INDUSTRIES, INC. (KR) | 2012-05-10 | — | — | US | disclosed |
| US-20120095017-A1 | PHARMACEUTICAL FORMULATIONS OF SUBSTITUTED AZAINDOLEOXOACETIC PIPERAZINE DERIVATIVES WITH PROTEASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY | 2012-04-19 | — | — | US | disclosed |
| US-20120043531-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME, AND DISPLAY DEVICE INCLUDING THE LIGHT EMITTING DIODE | CHEIL INDUSTRIES, INC. (KR) | 2012-02-23 | — | — | US | disclosed |
| WO-2012020848-A1 | HETEROCYCLIC COMPOUND AND USE THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2012-02-16 | — | — | WO | disclosed |
| US-20110245268-A1 | PHARMACEUTICAL FORMULATIONS OF SUBSTITUTED AZAINDOLEOXOACETIC PIPERAZINE DERIVATIVES WITH PROTEASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY | 2011-10-06 | — | — | US | disclosed |
| US-20110118279-A1 | PHARMACEUTICAL FORMULATIONS OF SUBSTITUTED AZAINDOLEOXOACETIC PIPERAZINE DERIVATIVES WITH PROTEASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY | 2011-05-19 | — | — | US | disclosed |
| US-20110009415-A1 | Thienopyridazine Compounds, Their Preparations, Pharmaceutical Compositions And Uses | WU, ZHANGGUI (CN) | 2011-01-13 | — | — | US | disclosed |
| US-20100256365-A1 | COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR | PLEXXIKON, INC. | 2010-10-07 | — | — | US | disclosed |
| CN-101333226-A | Chiral dual ring [4.4.0] diborate and method for preparing same | UNIV WUHAN (CN) | 2008-12-31 | — | — | CN | disclosed |
| CN-1282326-A | Anilide derivative, process for producing the same, and use thereof | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2001-01-31 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (16 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120112174-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME AND DISPLAY DEVICE INCLUDING THE ORGANIC LIGHT EMITTING DIODE | AOX1, OCIAD1, OCIAD2 | LMNA 4819/4885CYP2A6 411/4885MAOA 147/4885 |
| US-20240018103-A1 | 3-HYDROXYOXINDOLE DERIVATIVES AS CRHR2 ANTAGONIST | CRHR2, CRHR1, CRH | LMNA 3693/4885CYP2A6 1081/4885MAOA 642/4885 |
| US-20110009415-A1 | Thienopyridazine Compounds, Their Preparations, Pharmaceutical Compositions And Uses | CYP3A5, ABCC5, DPYD | LMNA 4144/4885CYP2A6 66/4885MAOA 2049/4885 |
| US-20110245268-A1 | PHARMACEUTICAL FORMULATIONS OF SUBSTITUTED AZAINDOLEOXOACETIC PIPERAZINE DERIVATIVES WITH PROTEASE INHIBITORS | PREP, PEPD, DNPEP | LMNA 4581/4885CYP2A6 575/4885MAOA 316/4885 |
| US-20240023432-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, MANUFACTURING METHOD THEREFOR, AND COMPOSITION FOR ORGANIC LAYER | CYP1B1, NOTUM, CYP4F11 | LMNA 1971/4885CYP2A6 241/4885MAOA 581/4885 |
| US-11805697-B2 | Organic electroluminescence device and monoamine compound for organic electroluminescence device | SLC18A2, SLC18A1, MAOA | LMNA 3034/4885CYP2A6 758/4885MAOA 3/4885 |
| US-20230371368-A1 | LIGHT EMITTING ELEMENT AND AMINE COMPOUND FOR THE SAME | SLC1A2, SLC18A1, SLC18A2 | LMNA 1964/4885CYP2A6 2090/4885MAOA 10/4885 |
| US-20240228470-A1 | Organic Compound And Organic Light Emitting Device Including Same | OR10J3, ORMDL3, OR51E2 | LMNA 3738/4885CYP2A6 1839/4885MAOA 635/4885 |
| US-20230389347-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | LEF1, L1CAM, RER1 | LMNA 847/4885CYP2A6 2780/4885MAOA 1303/4885 |
| US-20120095017-A1 | PHARMACEUTICAL FORMULATIONS OF SUBSTITUTED AZAINDOLEOXOACETIC PIPERAZINE DERIVATIVES WITH PROTEASE INHIBITORS | PREP, PEPD, DNPEP | LMNA 4581/4885CYP2A6 575/4885MAOA 316/4885 |
| US-11832512-B2 | Organic electroluminescence device and monoamine compound for organic electroluminescence device | MAOA, MAOB, AOC2 | LMNA 4156/4885CYP2A6 597/4885MAOA 1/4885 |
| US-20100256365-A1 | COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR | MAP3K20, MAP3K13, MAP3K8 | LMNA 2202/4885CYP2A6 4605/4885MAOA 4445/4885 |
| US-20120043531-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME, AND DISPLAY DEVICE INCLUDING THE LIGHT EMITTING DIODE | AOX1, OR10J3, OCIAD1 | LMNA 4792/4885CYP2A6 634/4885MAOA 252/4885 |
| US-12029112-B2 | Composition for optoelectronic device and organic optoelectronic device and display device | OR10J3, OCIAD2, OCIAD1 | LMNA 4756/4885CYP2A6 2129/4885MAOA 400/4885 |
| US-20110118279-A1 | PHARMACEUTICAL FORMULATIONS OF SUBSTITUTED AZAINDOLEOXOACETIC PIPERAZINE DERIVATIVES WITH PROTEASE INHIBITORS | PREP, PEPD, DNPEP | LMNA 4581/4885CYP2A6 575/4885MAOA 316/4885 |
| US-11840513-B2 | Substituted nicotinimide inhibitors of BTK for treating cancer | BTK, SYK, LYN | LMNA 3824/4885CYP2A6 2807/4885MAOA 1681/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.